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            Amendments from Version 1
To address the comments and suggestions made by the reviewers, 
we have:
1.     Added the age range of participants in the methods section of the 
abstract.
2.     Included the sample collection time in the Methods section under 
Study design.
3.     Added data on hepcidin/ferritin and transferrin saturation/hepcidin 
ratios to Table 1 and Table 3.
4.     Added a Supplementary file (Extended datafile 3) with iron and 






Malaria and iron deficiency are major public health prob-
lems for children living in sub-Saharan Africa. The major-
ity (94%) of the 405,000 global deaths due to malaria in 2018 
occurred in sub-Saharan Africa, where up to 24% of the popu-
lation have malaria parasitaemia at any given time1,2. In this 
region, iron deficiency (ID) and anaemia are highly prevalent3,4, 
and may lead to impaired brain development5,6, while iron defi-
ciency anaemia (IDA) is a leading cause of years lived with dis-
ability in African children7. Increasing evidence suggests that 
malaria may be contributing to ID and IDA8,9. Previous stud-
ies reported that the prevalence of ID and IDA increased over 
the malaria season in Gambian and Kenyan children10,11, and 
decreased with the interruption of malaria transmission in the 
Kenyan highlands12.
Multiple factors may contribute towards the development 
of ID and IDA following a malaria infection. One such fac-
tor is interferon-gamma (IFN-γ), which is induced during 
acute and persistent malaria infection13. Among other type 1 
responses, IFN-γ is involved in regulating erythropoiesis14–16 
and iron-regulatory proteins17–20. IFN-γ has also been reported to 
increase the expression of hepcidin17, and divalent metal trans-
porter 1 (DMT1)19, while suppressing ferroportin18,19, ferritin20, 
and transferrin receptors19,20. This regulation of iron proteins 
may be aimed at starving invading pathogens of iron, a critical 
nutrient for pathogen growth, but could also play an important 
role in the pathogenesis of ID and IDA. Indeed, higher IFN-γ 
levels have been reported in Kenyan children with severe 
malarial anaemia21.
Single nucleotide polymorphisms (SNPs) in the IFN-γ gene 
(IFNG) on chromosome 12q14 have been associated with 
increased production of IFN-γ22,23, and with susceptibility to 
severe malaria24,25. Despite evidence that malaria induces the 
production of IFN-γ13 and that this cytokine influences iron 
regulation17–20, it is not known whether variation in the IFNG 
gene influences the risk of ID and IDA among children in 
malaria-endemic areas. We investigated SNPs and haplotypes 
in the IFNG gene locus in relation to nutritional iron status and 
anaemia in a cohort of 780 Gambian children prior to and at the 
end of a malaria season, using an approach based on inform-




The study was conducted in ten rural villages in the West 
Kiang region of The Gambia at the start (July 2001) and end 
(December 2001/January 2002) of a malaria season, as previ-
ously described26. Malaria incidence is highly seasonal in The 
Gambia, with the majority of cases occurring between Sep-
tember and December. The study participants were from the 
Mandinka and Fulani ethnic groups. All of the Fulani chil-
dren were located in a single village and ethnic group was 
accounted for in all analyses by adjusting for village.
Study design
We used previously collected data from a cohort of 780 chil-
dren aged two to six years, recruited at the start of a malaria 
season as previously described26. All children had a clini-
cal examination and a blood sample collected in the morn-
ing between 6 and 11 am for full blood count, malaria film, and 
biomarkers of iron status and inflammation at the start and 
end of the malaria season. Children with pyrexia (tempera-
ture ≥37.5°C) had appropriate clinical investigations, clini-
cal treatment and a blood sample taken 2 weeks later after 
recovery from illness. All children received a 3-day course of 
mebendazole for possible hookworm infection at recruitment.
Laboratory procedures
Haemoglobin (Medonic CA 530 Haemoglobinometer) and zinc 
protoporphyrin (ZnPP) levels (Aviv Biomedical Hematoflurom-
eter) were measured within 24 hours of sample collection. 
Hepcidin (Hepcidin-25 [human] EIA kit; Bachem), ferri-
tin (IMx ferritin assay, Microparticle Enzyme Immunoassay; 
Abbot Laboratories), soluble transferrin receptor (sTfR, Human 
sTfR ELISA; R&D Systems), serum iron, unsaturated iron bind-
ing capacity (UIBC, Ferrozine-based photometry and colorim-
etry; Hitachi 911 automated analyzer), and α
1
-antichymotrypsin 
(ACT, immunoturbidimetry, Cobas Mira Plus Bioanalyzer, 
Roche) were assayed according to the manufacturers’ instruc-
tions from plasma samples stored at -80°C. Transferrin saturation 
(TSAT) was calculated from plasma iron and UIBC (TSAT 
= [plasma iron/ (UIBC + plasma iron)] X 100)27. Hepci-
din/ferritin and TSAT/hepcidin ratios were also calculated28. 
Giemsa-stained thick and thin blood films were examined for 
Plasmodium falciparum and other Plasmodium species at the 
start and end of the malaria season.
SNPs and haplotype construction
Genotypes were determined on whole-genome amplified DNA 
(primer extension pre-amplification) by the Agena Bioscience 
MassArray platform (formerly SEQUENOM) using matrix-
assisted laser desorption/ionization time-of-flight (MALDI-
TOF) mass spectrometry as previously described25. Details of 
the primer sequences and assays are given in Extended data-
files 1 and 229. The most informative haplotype-tagging SNPs 
(htSNPs) to type in Gambian subjects were identified by analysing 
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the pattern of linkage disequilibrium (LD) in the IFNG gene 
loci using previously available data from 32 Gambian family 
trios25,30. The PHASE program (http://stephenslab.uchicago.
edu/software.html) version 2.1 was used to infer haplotypes 
from the genotypes of the study population and estimate 
the frequency of each inferred haplotype31. The entropy 
maximization method was used to identify htSNPs that 
described >90% of the observed haplotypic diversity in this 
gene region30. The HaploXT program (http://www.sph.umich.
edu/csg/abecasis/GOLD/docs/haploxt.html) was used to esti-
mate pairwise LD statistics. Sickle cell (HbS, rs334) and 
glucose-6-phosphate deficiency (G6PD) deficiency (rs1050828 
and rs1050829) were also genotyped using the Agena Bioscience 
MassArray platform.
Definition of terms
Inflammation was defined as ACT >0.6 g/L. ID was defined as 
ferritin <12 µg/L or <30 µg/L in the presence of inflammation 
or <15 µg/L in children ≥5 years32, anaemia as Hb<11.0 g/dL 
(or Hb <11.5 g/dL in children ≥5 years) and IDA as ID plus 
anaemia33.
Statistical analyses
Statistical analyses were conducted using STATA 15.1 (Stata-
Corp. College Station, Texas, USA). Categorical data were 
expressed as proportions with corresponding percentages. 
Pearson chi-squared test was used to compare the prevalence 
of malaria and iron status (ID, IDA and anaemia) at the start 
and end of the malaria season. Changes in haemoglobin lev-
els and markers of iron status over the malaria season were 
assessed using the paired t-test. Biological data that were not 
normally distributed were log-transformed, and geometric means 
were calculated from original untransformed values.
Log-transformed markers of iron status and risk of ID, IDA 
and anaemia were analysed using univariable and multi-
variable linear and logistic regression models, as appropri-
ate. Multivariable regression models were adjusted for age 
(grouped by year), sex, village (which also acted as a proxy for 
ethnic group), malaria parasitaemia and ACT at the start and 
end of the malaria season. The Bonferroni correction for mul-
tiple testing34 was applied when the five SNPs and six hap-
lotypes were considered individually as independent factors. 
For multivariable analyses, P values are noted as adj. P for 
non-Bonferroni corrected analyses and as Bonferroni adj. P 
for multivariable analyses that are Bonferroni corrected, and 
for univariable models P values are similarly presented as P 
or Bonferroni P if Bonferroni corrected. All analyses were 
considered statistically significant at P <0.05.
Ethics
Individual written informed consent was obtained from chil-
dren’s parents or guardians and the study was approved by 
The Gambian Government and the Medical Research Council 
Ethics Review Committee (874/830).
Results
Characteristics of participants
A total of 756 children, including 403 males (53%) and 
353 females (47%), were followed up to the end of the malaria 
season. Most of the children were from the Mandinka ethnic 
group (n = 681; 90%, compared to Fulani n = 75; 10%). A total 
of 99/751 (13.2%) children carried sickle cell trait (HbAS) and 
136/683 (19.9%) children G6PD deficiency and the effects of 
these polymorphisms on iron status and anaemia are shown 
in Extended datafile 329. At the start of the malaria season we 
found little difference in iron status in children with HbAS and 
G6PD deficiency compared to those with wild-type. At the end 
of the malaria season, children carrying HbAS had lower zinc 
protoporphyrin levels (97.0 [95% CI 87.0, 108.2]) com-
pared to those with HbAA (115.9 [95% CI 110.6, 121.3]; 
adj. P = 0.05) and children with G6PD deficiency had 
lower haemoglobin levels (9.7 g/dl [95% CI 9.4, 10.0]) than 
those with G6PD wild-type genotype (10.0 g/dl [95% CI 9.9, 
10.2]; adj. P = 0.01). The prevalence of ID and IDA increased 
over the malaria season (from 20.6% to 31.6% and from 
11.9% to 21.7%, respectively), as previously reported11,26. Indi-
vidual markers of iron status also reflected an increase in ID 
over the malaria season. We found that hepcidin and hepci-
din/ferritin ratio decreased while the TSAT/hepcidin ratio 
increased across the malaria season in keeping with the need 
for increased erythropoiesis and increased rates of iron absorp-
tion at the end of the malaria season. Table 1 summarises the 
characteristics of the study population and their iron status 
at the beginning and end of the malaria season.
IFNG single nucleotide polymorphisms and associations
We identified five IFNG haplotype tagging SNPs at positions 
IFNG-1616 (rs2069705), IFNG+874 (rs2430561), IFNG+2200 
(rs1861493), IFNG+3234 (rs2069718) and IFNG+5612 
(rs2069728) relative to the ATG start codon (Figure 1, 
Extended datafile 129). All of the IFNG SNPs were in Hardy 
Weinberg equilibrium. The IFNG+2200C (rs1861493, n=97) 
allele was associated with a reduced risk of malaria parasi-
taemia at the end of the malaria season (adj. OR 0.40 [95% 
CI 0.21, 0.77]; Bonferroni adj. P=0.03) but not at the start. The 
other IFNG SNPs were not associated with malaria parasitae-
mia at either time point (Extended datafile 429). The IFNG SNPs 
were not associated with HbAS or G6PD genotypes follow-
ing Bonferroni correction in adjusted models. The IFNG+874T 
and IFNG+3234C alleles were associated with the Fulani eth-
nic group (OR 2.22 [95% CI 1.49, 3.31] Bonferroni P = 0.0005 
and OR 1.56 [95% CI 1.09, 2.24]; Bonferroni P = 0.045, 
respectively). The minor allele frequencies by ethnic group are 
presented in Extended datafile 129.
Associations with iron and anaemia
We found that the IFNG SNPs were not associated with ID, 
IDA or anaemia at the start of the malaria season in multivari-
able logistic regression analyses adjusted for age, sex, village, 
ACT and malaria parasitaemia following Bonferroni adjustment 
(Extended datafile 529).
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The IFNG SNPs were similarly not significantly associated 
with ID, IDA or anaemia at the end of the malaria season after 
Bonferroni correction. The IFNG+2200C allele (rs1861493) 
was associated with trends towards increased risk of anae-
mia (adj. OR 1.86 [95% CI 1.02, 3.38]; adj. P = 0.04), IDA 
(adj. OR 1.81 [95% CI 1.01, 3.25]; adj. P = 0.05), and ID (adj. 
OR 1.63 [95% CI 0.95, 2.80]; adj. P = 0.08) in multivariable 
logistic regression models, but not after Bonferroni correction 
(Table 2). Children carrying the IFNG+2200C allele had lower 
haemoglobin levels (9.7 g/dl [95% CI 9.4, 10.1]) compared 
to those with the IFNG+2200 TT genotype (10.0 g/dl [95% 




Age months, median (IQR) 46.11 (34.83, 59.17) 51.37 (40.47, 64.20)
Sex, Female (%) 353/756 (46.7%) 322/700 (46.0%)
Malaria parasitaemia (%) 89/754 (11.8%) 179/698 (25.6%)
Iron status* 
Iron deficiencya 151/734 (20.6%) 216/ 684 (31.6%)
Iron deficiency anaemiab 86/720 (11.9%) 146/673 (21.7%)
Anaemiac 475/736 (64.5%) 504/691 (72.9%)
Iron biomarkers** 
Hepcidin (ng/ml) 11.1 (9.9, 12.4) 4.2 (3.7, 4.8)
Hepcidin/ferritin 0.44 (0.40, 0.48) 0.20 (0.18, 0.23)
TSAT/hepcidin (%/ng/ml) 0.20 (0.18, 0.23) 1.16 (1.03, 1.31)
Ferritin (µg/L) 25.2 (23.6, 26.8) 20.6 (19.1, 22.2)
ZnPP (µmol/mol Hb) 86.4 (82.9, 90.0) 113.4 (108.7, 118.3)
sTfR (mg/L) 3.45 (3.36, 3.54) 4.16 (4.05, 4.28)
UIBC (µmol/L) 56.8 (55.7, 57.8) 62.7 (61.3, 64.2)
Serum iron (µmol/L) 8.6 (8.3, 9.0) 8.4 (8.2, 8.7)
TSAT (%) 12.9 (12.4, 13.4) 11.6 (11.1, 12.1)
Hb (g/dL) 10.6 (10.5, 10.7) 10.0 (9.8, 10.1)
* Frequency and percentages are shown. ** Geometric means and 95% CIs are 
shown. aIron deficiency was defined as ferritin <12µg/l (or ferritin <30µg/l in the 
presence of inflammation or <15 µg/L in children ≥ 5years)32; b iron deficiency 
anaemia as iron deficiencya and anaemiac; c anaemia as haemoglobin<11.0 g/dL 
or haemoglobin <11.5 g/dL in children ≥ 5years. ZnPP, zinc protopophyrin; TSAT, 
transferrin saturation; sTfR, soluble transferrin receptor; UIBC, unsaturated iron 
binding capacity; and Hb, haemoglobin.
Figure 1. Schematic representation of the IFNG gene locus. The IFNG single nucleotide polymorphisms (SNP) are designated according 
to the nucleotide position relative to the transcriptional starting site of IFNG.
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as well as a trend towards ID in other markers of iron status 
at the end of the malaria season in adjusted linear regression 
models (Table 3).
IFNG haplotypes
Haplotype analysis identified ten haplotypes (four with less 
than 1% population frequency) resolved by SNPs at nucle-
otide positions -1616, +874, +2200, +3234 and +5612 in the 
IFNG gene locus (Figure 1). Six haplotypes accounted for 
most of the variation. The wild-type haplotype (haplotype 1, 
IFNG-CATTC) was present at a frequency of 35% in the Gam-
bian children, while haplotype 6 (IFNG-CACTC), uniquely 
identified by the IFNG+2200 SNP, was present at a fre-
quency of 7%. Using haplotype 1 as the reference, haplotype 6 
was associated with a trend towards increased risk of ID (adj. 
OR 1.58 [95% CI 0.93, 2.69]), IDA (adj. OR 1.71 [95% CI 
0.94, 3.10]) and anaemia (adj. OR 1.67 [95% CI 0.93, 3.01]) 
at the end of the malaria season (Table 4). Haplotype 6 was 
also associated with reduced haemoglobin concentrations (adj. 
β -0.48 [95% CI -0.79, -0.18]; P = 0.002) and TSAT (adj. β -0.15 
[95% CI -0.27, -0.03]; P = 0.02), and higher ZnPP levels (adj. 
β 0.06 [95% CI 0.01, 0.12]; P = 0.02) and a trend towards 
reduced ferritin levels compared to the wild-type haplotype 
(Table 5).
Discussion
In this study we observed an increase in the prevalence of ID, 
IDA and anaemia across the malaria season in Gambian chil-
dren. Dietary iron insufficiency may be an important cause 
since the malaria season also coincides with the ‘hungry 
season’ in The Gambia when there is a scarcity of staple foods. 
We hypothesized that IFN-γ, a pro-inflammatory cytokine 
induced during malaria infection13, might play a role in influ-
encing the risk of ID and anaemia in children exposed to 
malaria. In addition to directly reducing erythrocyte half-life15, 
evidence suggests that IFN-γ induces hepcidin and inhibits 
ferroportin, hence reducing iron absorption and promot-
ing sequestration of iron in macrophages17,19. Consequently, 
high levels of IFN-γ induced during malaria infections may 
concomitantly lead to ID and anaemia.
We found that the IFNG+2200C (rs1861493) allele, located 
at intron 3 of the IFNG gene, was associated with reduced hae-


















rs2069705 IFNG -1616 CC 206 (29.9) Reference Reference Reference
IFNG -1616 CT 332 (48.2) 0.82 (0.53, 1.28) 0.40 1 0.62 (0.38, 1.02) 0.06 0.31 0.96 (0.59, 1.53) 0.85 1
IFNG -1616 TT 151 (21.9) 0.60 (0.34, 1.05) 0.07 0.37 0.53 (0.32, 1.09) 0.09 0.45 0.88 (0.50, 1.55) 0.66 1
rs2430561 IFNG+874 AA 509 (71.4) Reference Reference Reference
IFNG+874 AT 182 (25.5) 0.71 (0.44, 1.14) 0.22 0.76 0.75 (0.45, 1.25) 0.27 1 0.93 (0.59, 1.48) 0.76 1
IFNG+874 TT 22 (3.1) 0.29 (0.09, 0.99) 0.05 0.24 0.37 (0.09, 1.44) 0.15 0.75 0.62 (0.24, 1.63) 0.33 1
rs1861493e IFNG +2200 TT 598 (86.0) Reference Reference Reference
IFNG +2200 
CT/CC
97 (14.0) 1.63 (0.95, 2.80) 0.08 0.38 1.81 (1.01, 3.25) 0.05 0.23 1.86 (1.02, 3.38) 0.04 0.22
rs2069718 IFNG +3234 TT 393 (54.7) Reference Reference Reference
IFNG +3234 CT 268 (37.3) 0.87 (0.58, 1.32) 0.52 1 0.89 (0.56, 1.41) 0.62 1 0.95 (0.62, 1.45) 0.82 1
IFNG +3234 CC 58 (8.1) 0.79 (0.39, 1.60) 0.51 1 0.73 (0.33, 1.63) 0.44 1 0.67 (0.34, 1.32) 0.25 1
rs2069728 IFNG +5612 CC 326 (47.0) Reference Reference Reference
IFNG +5612 CT 302 (43.6) 0.85 (0.57, 1.28) 0.44 1 0.76 (0.48, 1.19) 0.22 1 0.94 (0.62, 1.42) 0.76 1
IFNG +5612 TT 65 (9.4) 0.97 (0.48, 1.96) 0.93 1 0.47 (0.20, 1.12) 0.09 0.45 0.94 (0.45, 1.95) 0.87 1
a Values are number (%) in each group; b Ferritin <12µg/l (or ferritin<30µg/l in the presence of inflammation or <15 µg/L in children ≥5 years)32; c Iron deficiencyb 
and anaemiad; d Haemoglobin<11.0g/dL (or haemoglobin<11.5g/dL in children ≥5years); e The mutant alleles for IFNG+2200 were combined because of the low 
frequency of IFNG+2200CC (n=4) in the study population; ¶ Odds ratios (OR) and P values were derived by multivariable logistic regression adjusted for age, sex, 
village (a proxy for location and ethnic group), α1-antichymotrypsin level and the presence of malaria parasites on blood film; 
*P values additionally adjusted for 
Bonferroni correction for multiple testing.
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Table 4. IFNG haplotypes and risk of iron deficiency, iron deficiency anaemia and anaemia at the end of the 
malaria season.
Hap ID Haplotypea Freq (No) Iron Deficiencyb Iron Deficiency 
Anaemiac
Anaemiad
OR (95% CI)¶ Adj P¶ OR (95% CI)¶ Adj P¶ OR (95% CI)¶ Adj P¶
Hap1 CATTC 0.35 (536) Reference Reference Reference
Hap2 TATT T 0.19 (283) 0.82 (0.55, 1.21) 0.31 0.69 (0.44, 1.07) 0.10 1.08 (0.72, 1.60) 0.72
Hap3 TTT CC 0.16 (240) 0.70 (0.46, 1.06) 0.09 0.68 (0.43, 1.08) 0.10 0.83 (0.56, 1.24) 0.37
Hap4 CATT T 0.11 (171) 1.14 (0.73, 1.78) 0.73 0.91 (0.53, 1.56) 0.73 0.78 (0.50, 1.23) 0.28
Hap5 TAT CC 0.11 (166) 1.19 (0.77, 1.85) 0.58 0.91 (0.53, 1.55) 0.73 1.03 (0.65, 1.66) 0.89
Hap6 CA CTC 0.07 (100) 1.58 (0.93, 2.69) 0.09 1.71 (0.94, 3.10) 0.09 1.67 (0.93, 3.01) 0.09
a The haplotype configuration is as follows: IFNG-1616, IFNG+874, IFNG+2200, IFNG+3234, IFNG+5612. Minor alleles are indicated 
by bold type; b ferritin <12µg/l (or ferritin<30µg/l in the presence of inflammation or <15 µg/L in children ≥5 years)32; c iron deficiency 
and anaemia; d haemoglobin<11.0g/dL (or haemoglobin<11.5g/dL in children ≥5years); ¶ odds ratios (OR) and P values were 
derived by multivariable logistic regression adjusted for age, sex, village, α1-antichymotrypsin level and malaria parasitaemia. Hap, 
haplotype; Freq, frequency of the haplotypes in the study population; no, number of haplotype alleles in the study population.
Table 3. IFNG+2200 SNPs and markers of iron status at the end of the malaria season.
Iron Marker n IFNG+2200 TTa,b n IFNG+2200 CT/CCa,b Adj P ¶ Bf adj P*
Hepcidin (ng/ml) 500 4.4 (3.8, 5.1) 84 3.2 (2.2, 4.6) 0.09 0.44
Hepcidin/ferritin 500 0.20 (0.18, 0.23) 84 0.18 (0.14, 0.25) 0.19 0.94
TSAT/hepcidin (%/ng/ml) 490 2.75 (2.38, 3.17) 81 3.33 (2.38, 4.67) 0.87 1
Ferritin (µg/L) 545 21.4 (19.7, 23.2) 91 16.9 (13.6, 21.1) 0.04 0.21
ZnPP (µmol/mol Hb) 550 112.4 (107.2, 117.8) 91 121.2 (107.0, 137.3) 0.06 0.32
sTfR (mg/L) 508 4.2 (4.0, 4.3) 86 4.2 (3.9, 4.6) 0.38 1
UIBC (µmol/L) 530 61.6 (60.1, 63.2) 87 67.9 (62.6, 73.8) 0.04 0.19
Serum iron (µmol/L) 532 8.6 (8.3, 8.9) 88 7.9 (7.1, 8.7) 0.19 0.95
TSAT (%) 528 12.0 (11.4, 12.5) 87 10.1 (8.8, 11.6) 0.04 0.19
Hb (g/dL) 546 10.0 (9.8, 10.1) 92 9.7 (9.4, 10.1) 0.006 0.03
a Values are geometric means (95% confidence interval); b The wild-type alleles represent children with IFNG+2200TT 
genotype (n=598). The mutant alleles represent children with the IFNG+2200TC (n=93) and IFNG+2200CC (n=4) 
genotypes combined; ¶ Significance values were derived by multivariable linear regression with each log-transformed 
iron marker as a dependent variable and adjusted for age, sex, village (a proxy for location and ethnic group), α1-
antichymotrypsin level and the presence of malaria parasites on blood film. * P values adjusted for Bonferroni correction 
for the five tested SNPs. n, number of children; Hb, haemoglobin; ZnPP, zinc protopophyrin; sTfR, soluble transferrin 
receptor; UIBC, unsaturated iron binding capacity; and TSAT, transferrin saturation.
at the end of a malaria season in multivariable analyses 
adjusting for potential confounders. We then constructed haplo-
types to increase the probability of capturing functional muta-
tions which might reside within a given haplotype. Haplotype 6 
(uniquely identified by the IFNG+2200C allele), was associated 
with reduced haemoglobin levels and TSAT and increased 
ZnPP levels in keeping with iron deficiency compared to 
the wild-type haplotype. Haplotype 6 was similarly asso-
ciated with trends towards increased risk of ID, IDA and 
anaemia at the end of the malaria season.
So how might the IFNG+2200C genotype and a haplotype 
uniquely defined by this genotype potentially lead to reduced 
haemoglobin levels and ID at the end of the malaria season? 
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A possible explanation may be through increasing IFNG 
gene expression and IFN-γ levels. The IFNG+2200C allele was 
associated with increased IFN-γ levels in Kawasaki disease 
patients23, although another study in patients with ankylosing 
spondylitis found no difference in IFN-γ levels by IFNG+2200 
genotype35. Elevated IFN-γ levels promote dyserythropoiesis, 
anaemia and iron dysregulation. IFN-γ inhibits proliferation 
of erythroid progenitor cells by disrupting lineage differentia-
tion, blocking renal production of erythropoietin, inhibiting renal 
iron reabsorption, and reducing red blood cell half-life14–16,36. As 
a type 1 immune response, IFN-γ also induces defensive tran-
scriptional programs within enterocytes resulting in reduced 
dietary iron absorption37. Additionally, IFN-γ promotes iron 
sequestration in macrophages either directly or through its influ-
ence on hepcidin, ferroportin, and DMT117–20. These responses 
reduce circulating transferrin-bound iron, which is required 
by Plasmodium parasites for metabolism and proliferation38. 
In keeping with this, we observed decreased ferritin lev-
els and TSAT and increased ZnPP levels in children carrying 
the IFNG+2200C haplotype. Lower haemoglobin levels may 
also translate into reduced amino acid availability for Plas-
modium parasites39 and hence protection against blood-stage 
parasitaemia. Indeed, we observed that the IFNG+2200C 
SNP was associated with protection against malaria parasitae-
mia at the end of the malaria season (adj. OR 0.40; Bonferroni 
adj. P=0.03).
The influence of the IFNG+2200C allele on haemoglobin and 
iron status was only observed at the end of the malaria sea-
son. We hypothesized that the effects of this SNP may be 
most marked when expression of IFNG is upregulated, such 
as during malaria infections13,24. This also highlights the 
influence of gene-environment interactions in promoting dis-
ease, in this case ID, IDA and anaemia. It is unlikely that the 
decreased haemoglobin levels observed in individuals carry-
ing the IFNG+2200C allele was due to increased malaria since 
these children had reduced prevalence of malaria parasitaemia 
at the end of the malaria season. It is possible that higher IFN-γ 
levels, putatively produced by IFNG+2200C carriers, may induce 
a protective proinflammatory response against malaria13,40, 
but at the expense of iron homeostasis. The IFNG+874TT 
(rs2430561) genotype, located at the first intron coinciding with 
the NFkB binding region, has also been associated with higher 
production of IFN-γ22,35,41. However, studies have found no 
association between IFNG+874TT and malaria25 or aplas-
tic anaemia42, and in our study we observed a trend towards a 
decreased risk of ID in these individuals. Further investigations 
are required on a cellular level to explore putative functional 
effects of IFNG genotypes on IFN-γ levels and iron status.
To our knowledge, this is the first study examining the role 
of IFNG gene polymorphisms in relation to iron status. We 
found that the IFNG+2200C (rs1861493) allele, and a hap-
lotype defined by this allele, were associated with reduced 
haemoglobin levels and a trend towards ID at the end of the 
malaria season, a finding that may be due to increased IFN-γ 
levels23. However, our study had a number of important limita-
tions and our findings should be viewed with considerable cau-
tion. The study was conducted in a single site and had relatively 
small numbers (n = 756). Additionally, many of our findings were 
of marginal significance with wide confidence intervals and lost 
statistical significance after correction for multiple testing with 
Bonferroni adjustment. It is also unclear if our findings have 
clinical relevance at an individual level. The IFNG+2200C SNP 
may also be in linkage disequilibrium (LD) with another genetic 
variant within the haplotype that might influence IFN-γ lev-
els and / or measures of iron status in Gambian populations. 
Finally, we did not measure IFN-γ levels to determine if they 
differed between genotypes at the end of the malaria season. 
Thus, our findings need to be examined in larger population-
based studies, in other malaria-exposed populations, and func-
tional assays are needed to identify whether genetic variation 
in the IFNG gene influences iron status. However, our study 
supports the hypothesis that preventing and treating malaria 




Havard Dataverse: Replication Data for: Interferon-gamma poly-
morphisms and risk of iron deficiency and anaemia in Gambian 
children, https://doi.org/10.7910/DVN/2NKJID43. This project 
contains the following underlying data:
•       IFNG_final_data_v2 (dataset containing demo-
graphic information and results of laboratory assays for 
participants included in the study).
•       IFNG_analysis_KM (contains the codes used for data 
analysis).
•       KMokaya_IFNG_Codebook (contains variable description 
and labels).
•       Data are available under the terms of the Creative 
Commons Attribution 4.0 International license 
(CC-BY 4.0).
Extended Data
Figshare: IFNG polymorphisms in Gambian children and 
risk of iron deficiency and anaemia, https://doi.org/10.6084/
m9.figshare.11807277.v629.
This project contains the following extended data:
Extended datafile 1. Assayed IFNG single nucleotide 
polymorphisms
Extended datafile 2. Agena Biosciences (formerly SEQUE-
NOM) MassARRAY® primer-extension definitions data for the 
five IFNG polymorphisms
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Extended datafile 3. Markers of iron status at the end of 
the malaria season in children with sickle cell trait and 
glucose-6-phosphate dehydrogenase deficiency
Extended datafile 4. IFNG single nucleotide polymorphisms 
and risk of malaria parasitemia at the start and end of the 
malaria season
Extended datafile 5. IFNG genotypes and risk of iron defi-
ciency, iron deficiency anaemia and anaemia at the start of the 
malaria season
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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a) Serum hepcidin levels are influenced by circadian rhythm and serum/iron stores.
Please indicate at what time of the day blood was drawn.
Response: Thank you, Blood was drawn from the participants in the morning hours (between 6 and
11AM). We have updated the study design section to indicate the time of sample collection.
 “Methods, under Study design: All children had a clinical examination and a blood sample
collected in the morning between 6 and 11 am for full blood count, malaria film, and biomarkers of
iron status and inflammation at the start and end of the malaria season.”
b) To “normalize” serum hepcidin to body iron concentration, the hepcidin/ferritin or
hepcidin/TSAT ratio should be shown in Table 1 and Table 3 (as in Donker et al., Pediatric
Blood and Cancer 2019).
Response: Thank you for the suggestion. We have added hepcidin/ferritin and transferrin
saturation (TSAT)/hepcidin ratios to tables 1 and 3. We have also made the following changes:
Methods section under laboratory methods: Hepcidin/ferritin and TSAT/hepcidin ratios were also
.calculated
Results section under Characteristics of participants: We found that hepcidin and hepcidin/ferritin
ratio decreased while the TSAT/hepcidin ratio increased across the malaria season in keeping with
the need for increased erythropoiesis and increased rates of iron absorption at the end of the
1
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the need for increased erythropoiesis and increased rates of iron absorption at the end of the
malaria season.
 
2. In the M&M section, the authors claim that some children are carriers of the HbAS, and
G6PD deficiency. Is it possible to present the haematological and iron data (in Table 1 and
Table 3) related to these children?
Response: Thank you for this suggestion. We have now added haemoglobin and iron biomarker
data for children with HbAS and G6PD deficiency as a Supplementary file (Extended datafile 3)
that can be accessed on Figshare (https://doi.org/10.6084/m9.figshare.11807277.v6). We have
also made the following changes to the Results section:
Results under Characteristics of participants: “A total of 99/751 (13.2%) children carried sickle cell
trait (HbAS) and 136/683 (19.9%) children G6PD deficiency and the effects of these
polymorphisms on iron status and anaemia are shown in Extended datafile 3.  At the start of the
malaria season we found little difference in iron status in children with HbAS and G6PD deficiency
compared to those with wild-type. At the end of the malaria season, children carrying HbAS had
lower zinc protoporphyrin levels (97.0 [95% CI 87.0, 108.2]) compared to those with HbAA (115.9
[95% CI 110.6, 121.3]; adj. P = 0.05) and children with G6PD deficiency had lower haemoglobin
levels (9.7 g/dl [95% CI 9.4, 10.0]) than those with G6PD wild-type genotype (10.0 g/dl [95% CI
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Abstract: It would be good if the authors provided the age range of children
enrolled in the study (2 – 6 years).This could be added in the Methods section at the
end of the sentence ‘….780 Gambian children.’
Response: Thank you for the suggestion. We have added the age range (2-6 years) in the
methods section of the abstract.
 
Abstract, Methods: “We used previously available data from Gambian family trios to determine
informative SNPs and then used the Agena Bioscience MassArray platform to type five SNPs from
the IFNG gene in a cohort of 780 Gambian children aged 2-6 years”.
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informative SNPs and then used the Agena Bioscience MassArray platform to type five SNPs from
the IFNG gene in a cohort of 780 Gambian children aged 2-6 years”.
 
2. The last sentence at the end of the Results section mentions a number of covariates
that were adjusted for in the models. One such covariate is ‘malaria parasitaemia’. 
a) Was malaria parasitaemia adjusted for only at the beginning and at the end of the
malaria season or did it capture all the malaria cases during the study period?
 
Response: In the current analysis, we adjusted for malaria parasitaemia detected on blood film at
the beginning and at the end of the malaria season, at the same timepoints when iron biomarkers
were measured since malaria parasitaemia influences markers of iron status. We did not monitor
for malaria cases during the malaria season. 
Methods, under Statistical analyses: “Multivariable regression models were adjusted for age
(grouped by year), sex, village (which also acted as a proxy for ethnic group), malaria parasitaemia
and ACT at the start and end of the malaria season.”
b)  Does ‘malaria parasitaemia’ mean malaria episodes during the study period?
Response: Malaria parasitaemia referred to the identification of Plasmodium parasites on the blood
film taken from the study participants at either of the two cross-sectional timepoints, i.e. at the
beginning and / or end of the malaria season. It does not refer to malaria episodes during the study
period.
 
c) If it only captures the two time points, what would the effect of ‘additional episodes’
during the study period have on the results? In malaria endemic areas, repeated
infections are more likely to result in anaemia than just the patent infection. The authors
need to clarify on this and if there were no malaria cases in-between the two time-points
they need to indicate so.
Response: We agree that repeated malaria episodes would increase the risk of anaemia. Based
on published data we estimated that the majority of the children would be likely to have had one or
more episodes of malaria over the malaria season during the study period.  Studies indicate that
malaria increases IFN-g levels  and that IFN-g regulates erythropoiesis and iron-regulatory
 proteins including hepcidin. We therefore hypothesized that IFNG SNPs, which might alter IFNG
expression, would influence iron status at the end of the malaria season. Thus, we would expect
that the effect of ‘additional episodes’ of malaria would be to increase malaria-induced IFN-g
 levels and IFN-g -induced iron deficiency and anaemia. To clarify we have updated the Methods
section as follows: 
Methods, under Laboratory methods: “Giemsa-stained thick and thin blood films were examined
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Abstract: It would be good if the authors provided the age range of children
enrolled in the study (2 – 6 years).This could be added in the Methods section at the
end of the sentence ‘….780 Gambian children.’
 
Response: Thank you for the suggestion. We have added the age range (2-6 years) in the
methods section of the abstract.
 
Abstract, Methods: “We used previously available data from Gambian family trios to determine
informative SNPs and then used the Agena Bioscience MassArray platform to type five SNPs from
the IFNG gene in a cohort of 780 Gambian children aged 2-6 years”.
 
2. The last sentence at the end of the Results section mentions a number of covariates
that were adjusted for in the models. One such covariate is ‘malaria parasitaemia’. 
a) Was malaria parasitaemia adjusted for only at the beginning and at the end of the
malaria season or did it capture all the malaria cases during the study period?
 
Response: In the current analysis, we adjusted for malaria parasitaemia detected on blood film at
the beginning and at the end of the malaria season, at the same timepoints when iron biomarkers
were measured since malaria parasitaemia influences markers of iron status. We did not monitor
for malaria cases during the malaria season. 
Methods, under Statistical analyses: “Multivariable regression models were adjusted for age
(grouped by year), sex, village (which also acted as a proxy for ethnic group), malaria parasitaemia
and ACT at the start and end of the malaria season.”
 
b) Does ‘malaria parasitaemia’ mean malaria episodes during the study period?
Response: Malaria parasitaemia referred to the identification of Plasmodium parasites on the blood
film taken from the study participants at either of the two cross-sectional timepoints, i.e. at the
beginning and / or end of the malaria season. It does not refer to malaria episodes during the study
period.
 
c) If it only captures the two time points, what would the effect of ‘additional episodes’
during the study period have on the results? In malaria endemic areas, repeated
infections are more likely to result in anaemia than just the patent infection. The authors
need to clarify on this and if there were no malaria cases in-between the two time-points
they need to indicate so.
Response: We agree that repeated malaria episodes would increase the risk of anaemia. Based
on published data we estimated that the majority of the children would be likely to have had one or
more episodes of malaria over the malaria season during the study period.  Studies indicate that
malaria increases IFN-g levels  and that IFN-g regulates erythropoiesis and iron-regulatory
 proteins including hepcidin. We therefore hypothesized that IFNG SNPs, which might alter IFNG
expression, would influence iron status at the end of the malaria season. Thus, we would expect
that the effect of ‘additional episodes’ of malaria would be to increase malaria-induced IFN-g
 levels and IFN-g -induced iron deficiency and anaemia. To clarify we have updated the Methods
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section as follows: 
Methods, under Laboratory methods: “Giemsa-stained thick and thin blood films were examined
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